Streptococcus Pneumoniae Infections
6
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (6)
Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
Nasopharyngeal Streptococcus Pneumoniae Carriage
Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, China
Study of Two Investigational Pneumococcal Vaccines in Healthy Adults